| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.21▼ | 5.10▼ | 4.96▲ | 4.45▲ | 3.78▲ |
| MA10 | 5.18▼ | 4.68▲ | 4.60▲ | 4.00▲ | 3.33▲ |
| MA20 | 4.84▲ | 4.28▲ | 4.12▲ | 3.71▲ | 3.36▲ |
| MA50 | 4.23▲ | 3.84▲ | 3.65▲ | 3.22▲ | 3.64▲ |
| MA100 | 3.71▲ | 3.41▲ | 3.30▲ | 3.35▲ | 2.74▲ |
| MA200 | 3.34▲ | 3.16▲ | 3.12▲ | 3.90▲ | 2.30▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | 0.096▲ | 0.124▲ | 0.152▲ | 0.164▲ |
| RSI | 58.156▲ | 63.832▲ | 65.523▲ | 75.505▲ | 66.130▲ |
| STOCH | 67.172 | 83.233▲ | 89.576▲ | 62.220 | 72.859 |
| WILL %R | -59.712 | -28.041 | -20.596▲ | -15.385▲ | -10.828▲ |
| CCI | -26.139 | 85.353 | 98.813 | 213.396▲ | 272.013▲ |
|
Tuesday, April 28, 2026 05:45 AM
Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.
|
|
Monday, April 27, 2026 11:39 AM
LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data ...
|
|
Monday, April 13, 2026 11:58 AM
LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company advancing cancer treatments, announced preliminary results from a clinical trial evaluating its proprietary ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 4.9379 | 5.50 | 4.75 | 5.16 | 124,305 |
| 07/05/26 | 4.32 | 5.00 | 3.965 | 4.93 | 162,899 |
| 06/05/26 | 4.55 | 4.55 | 3.961 | 4.40 | 99,643 |
| 05/05/26 | 3.33 | 4.53 | 3.30 | 4.485 | 211,797 |
| 04/05/26 | 3.3001 | 3.44 | 3.29 | 3.29 | 7,027 |
| 01/05/26 | 3.42 | 3.4416 | 3.3401 | 3.37 | 7,564 |
| 30/04/26 | 3.46 | 3.58 | 3.44 | 3.50 | 14,639 |
| 29/04/26 | 3.69 | 3.73 | 3.3661 | 3.50 | 13,030 |
| 28/04/26 | 3.685 | 3.685 | 3.41 | 3.60 | 23,122 |
| 27/04/26 | 3.70 | 3.9032 | 3.70 | 3.80 | 17,014 |
|
|
||||
|
|
||||
|
|